|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Wang JS, Huang T, Su J, et al:
Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village,
Fusui County, People’s Republic of China. Cancer Epidemiol
Biomarkers Prev. 10:143–146. 2001.PubMed/NCBI
|
|
3
|
Coleman WB: Mechanisms of human
hepatocarcinogenesis. Curr Mol Med. 3:573–588. 2003. View Article : Google Scholar
|
|
4
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar
|
|
5
|
Yu W, Andersson B, Worley KC, et al:
Large-scale concatenation cDNA sequencing. Genome Res. 7:353–358.
1997.PubMed/NCBI
|
|
6
|
Winfield SL, Tayebi N, Martin BM, Ginns EI
and Sidransky E: Identification of three additional genes
contiguous to the glucocerebrosidase locus on chromosome 1q21:
implications for Gaucher disease. Genome Res. 7:1020–1026.
1997.PubMed/NCBI
|
|
7
|
Ludes-Meyers JH, Kil H, Bednarek AK, Drake
J, Bedford MT and Aldaz CM: WWOX binds the specific proline-rich
ligand PPXY: identification of candidate interacting proteins.
Oncogene. 23:5049–5055. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kallin A, Johannessen LE, Cani PD, et al:
SREBP-1 regulates the expression of heme oxygenase 1 and the
phosphatidylinositol-3 kinase regulatory subunit p55γ. J Lipid Res.
48:1628–1636. 2007.PubMed/NCBI
|
|
9
|
Abdeen SK, Salah Z, Maly B, et al: Wwox
inactivation enhances mammary tumorigenesis. Oncogene.
30:3900–3906. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Huang CJ, Tian Y, Wang YP, Han ZG
and Li XC: Ectopic overexpression of COTE1 promotes cellular
invasion of hepatocellular carcinoma. Asian Pac J Cancer Prev.
13:5799–5804. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ren F, Wu H, Lei Y, et al: Quantitative
proteomics identification of phosphoglycerate mutase 1 as a novel
therapeutic target in hepatocellular carcinoma. Mol Cancer.
9:812010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang J, Zheng DL, Qin FS, et al: Genetic
and epigenetic silencing of SCARA5 may contribute to human
hepatocellular carcinoma by activating FAK signaling. J Clin
Invest. 120:223–241. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim TM, Yim SH, Shin SH, et al: Clinical
implication of recurrent copy number alterations in hepatocellular
carcinoma and putative oncogenes in recurrent gains on 1q. Int J
Cancer. 123:2808–2815. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong N, Lam WC, Lai PB, Pang E, Lau WY and
Johnson PJ: Hypomethylation of chromosome 1 heterochromatin DNA
correlates with q-arm copy gain in human hepatocellular carcinoma.
Am J Pathol. 159:465–471. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong N, Chan A, Lee SW, et al: Positional
mapping for amplified DNA sequences on 1q21–q22 in hepatocellular
carcinoma indicates candidate genes overexpression. J Hepatol.
38:298–306. 2003.PubMed/NCBI
|
|
16
|
Aqeilan RI, Donati V, Gaudio E, et al:
Association of Wwox with ErbB4 in breast cancer. Cancer Res.
67:9330–9336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Del Mare S, Salah Z and Aqeilan RI: WWOX:
its genomics, partners, and functions. J Cell Biochem. 108:737–745.
2009.PubMed/NCBI
|
|
18
|
Kurek KC, Del Mare S, Salah Z, et al:
Frequent attenuation of the WWOX tumor suppressor in osteosarcoma
is associated with increased tumorigenicity and aberrant RUNX2
expression. Cancer Res. 70:5577–5586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang NS, Pratt N, Heath J, Schultz L,
Sleve D, Carey GB and Zevotek N: Hyaluronidase induction of a WW
domain-containing oxidoreductase that enhances tumor necrosis
factor cytotoxicity. J Biol Chem. 276:3361–3370. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aqeilan RI, Donati V, Palamarchuk A,
Trapasso F, et al: WW domain-containing proteins, WWOX and YAP,
compete for interaction with ErbB-4 and modulate its
transcriptional function. Cancer Res. 65:6764–6772. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aderca I, Moser CD, Veerasamy M, et al:
The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced
by the tumor suppressor WWOX. J Hepatol. 49:373–383. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hong Q, Sze CI, Lin SR, et al: Complement
C1q activates tumor suppressor WWOX to induce apoptosis in prostate
cancer cells. PLoS One. 4:e57552009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Teng CC, Yang YT, Chen YC, Kuo YM and Sze
CI: Role of WWOX/WOX1 in Alzheimer’s disease pathology and in cell
death signaling. Front Biosci (Elite Ed). 4:1951–1965. 2012.
|
|
24
|
Park SW, Ludes-Meyers J, Zimonjic DB,
Durkin ME, Popescu NC and Aldaz CM: Frequent downregulation and
loss of WWOX gene expression in human hepatocellular carcinoma. Br
J Cancer. 91:753–759. 2004.PubMed/NCBI
|
|
25
|
Nunez MI, Ludes-Meyers J, Abba MC, et al:
Frequent loss of WWOX expression in breast cancer: correlation with
estrogen receptor status. Breast Cancer Res Treat. 89:99–105. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aqeilan RI and Croce CM: WWOX in
biological control and tumorigenesis. J Cell Physiol. 212:307–310.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ramos D, Abba M, López-Guerrero JA, et al:
Low levels of WWOX protein immunoexpression correlate with tumour
grade and a less favourable outcome in patients with urinary
bladder tumours. Histopathology. 52:831–839. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gourley C, Paige AJ, Taylor KJ, et al:
WWOX gene expression abolishes ovarian cancer tumorigenicity in
vivo and decreases attachment to fibronectin via integrin alpha3.
Cancer Res. 69:4835–4842. 2009. View Article : Google Scholar
|
|
29
|
Chang NS, Doherty J and Ensign A: JNK1
physically interacts with WW domain-containing oxidoreductase
(WOX1) and inhibits WOX1-mediated apoptosis. J Biol Chem.
278:9195–9202. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen ST, Chuang JI, Cheng CL, Hsu LJ and
Chang NS: Light-induced retinal damage involves tyrosine33
phosphorylation, mitochondrial and nuclear translocation of WW
domain-containing oxidoreductase in vivo. Neuroscience.
130:397–407. 2005. View Article : Google Scholar
|
|
31
|
Yang G, Zhang G, Pittelkow MR, Ramoni M
and Tsao H: Expression profiling of UVB response in melanocytes
identifies a set of p53-target genes. J Invest Dermatol.
126:2490–2506. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gaudio E, Palamarchuk A, Palumbo T,
Trapasso F, Pekarsky Y, Croce CM and Aqeilan RI: Physical
association with WWOX suppresses c-Jun transcriptional activity.
Cancer Res. 66:11585–11589. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang NS, Doherty J, Ensign A, Schultz L,
Hsu LJ and Hong Q: WOX1 is essential for tumor necrosis factor-, UV
light-, staurosporine-, and p53-mediated cell death, and its
tyrosine 33-phosphorylated form binds and stabilizes serine
46-phosphorylated p53. J Biol Chem. 280:43100–43108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salah Z, Aqeilan R and Huebner K: WWOX
gene and gene product: tumor suppression through specific protein
interactions. Future Oncol. 6:249–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Płuciennik E, Nowakowska M, Wujcicka WI,
Sitkiewicz A, Kazanowska B, Zielińska E and Bednarek AK: Genetic
alterations of WWOX in Wilms’ tumor are involved in its
carcinogenesis. Oncol Rep. 28:1417–1422. 2012.PubMed/NCBI
|
|
36
|
Nishida N, Fukuda Y, Komeda T, et al:
Amplification and overexpression of the cyclin D1 gene in
aggressive human hepatocellular carcinoma. Cancer Res.
54:3107–3110. 1994.PubMed/NCBI
|
|
37
|
Deane NG, Parker MA, Aramandla R, et al:
Hepatocellular carcinoma results from chronic cyclin D1
overexpression in transgenic mice. Cancer Res. 61:5389–5395.
2001.PubMed/NCBI
|
|
38
|
Tashiro E, Tsuchiya A and Imoto M:
Functions of cyclin D1 as an oncogene and regulation of cyclin D1
expression. Cancer Sci. 98:629–635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Geng Y, Yu Q, Sicinska E, Das M, et al:
Cyclin E ablation in the mouse. Cell. 114:431–443. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hwang HC and Clurman BE: Cyclin E in
normal and neoplastic cell cycles. Oncogene. 24:2776–2786. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chang JY, He RY, Lin HP, et al: Signaling
from membrane receptors to tumor suppressor WW domain-containing
oxidoreductase. Exp Biol Med. 235:796–804. 2010. View Article : Google Scholar
|
